Cas No.: 1228992-90-2
PRODUCT INFORMATION
Description
Cyclo(RGDfK(Mal)) is a maleimide-modified cyclic pentapeptide designed to mimic extracellular matrix interactions, thereby enhancing cellular adhesion. Its RGD motif targets integrins, while the maleimide group allows for covalent conjugation. It is a critical component for functionalizing advanced 3D biomaterial scaffolds, enabling scalable stem cell culture and controlled expansion under physiologically relevant in vitro conditions.
Molecular Weight
754.79
Purity
> 95%
Formula
C₃₄H₄₆N₁₀O₁₀
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Lys(MAL)]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- H-Gly-Arg-Gly-Asp-Ser-NH2 Targeting Peptide (CAT#: OLY-1025-YS-15)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.